Abstract:Objective This study aims to assess the feasibility of detecting and diagnosing Duchenne muscular dystrophy (DMD) during prenatal screening for chromosome abnormalities using cell-free fetal DNA extracted from peripheral blood samples of pregnant women. Study Design Two pregnant women identified as high risk through noninvasive prenatal testing (NIPT) underwent amniocentesis to obtain fetal cells. Subsequent fetal chromosomal karyotyping was conducted, and genomic DNA from fetal cells was extracted for copy number variation sequencing (CNV-Seq) analysis, complemented by multiplex ligation-dependent probe amplification (MLPA) to detect deletions or duplications within the DMD gene. Results NIPT results for the two samples indicated potential abnormalities involving chromosomes 21 and 18. However, karyotype analysis of the fetuses revealed no abnormalities. CNV-Seq identified deletions of 0.28 and 0.18 Mb within chromosome Xp21.1, encompassing the DMD gene, in each fetus. In family 1, MLPA results indicated a maternal heterozygous deletion spanning exons 12 to 41 in the DMD gene, while the fetus exhibited deletions in exons 12 to 41. In family 2, MLPA results confirmed normal DMD gene status in the pregnant woman's peripheral blood genomic DNA but revealed a fetal deletion spanning exons 48 to 52. Both fetuses were diagnosed with DMD and subsequently underwent termination. Conclusion Abnormalities identified through NIPT necessitate further invasive prenatal diagnostic procedures. For cases involving chromosomal microdeletions or microduplications, a combination of karyotyping and CNV-Seq testing is essential for comprehensive diagnosis. NIPT followed by CNV-Seq may offer insights into large exon deletions within the DMD gene in specific instances. Key Points NIPT results can offer valuable insights into the deletion and duplication of DMD gene for the fetus. It's crucial to notice unexpected findings in NIPT. A combination of karyotyping and CNV-Seq testing is essential for comprehensive diagnosis. Conceptualization: X.K., G.Z.; investigation: G.Z., L.L., P.S.; data curation: G.Z., M.G., S.Y.; experiment curation: G.Z.; writing—original draft: G.Z.; writing—review and editing: X.K.; funding acquisition: G.Z. All authors contributed to the article and approved the submitted version. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. Received: 23 September 2024 Accepted: 30 October 2024 Accepted Manuscript online: 04 November 2024 Article published online: 25 November 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Primary Study on Prenatal Diagnosis of Duchenne Muscular Dystrophy

Study on Duchenne muscular dystrophy gene mutation and prenatal diagnosis]

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

Development of a Comprehensive Real-Time PCR Assay for Dystrophin Gene Analysis and Prenatal Diagnosis of Chinese Families.

[Analysis of Results of Prenatal Diagnosis for 67 Pedigrees Affected with Duchenne Muscular Dystrophy in the Central Plain Region of China].

[Prenatal Diagnosis of Spinal Muscular Atrophy Using Multiple Ligation-Dependent Probe Amplification].

Combined screening of multiplex polymerase chain reaction and denaturing high-performance liquid chromatography in Duchenne muscular dystrophy with mutation deletion

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

[Mutation analysis and prenatal diagnosis of sporadic DMD/BMD families].

Haplotype-Based Approach for Noninvasive Prenatal Tests of Duchenne Muscular Dystrophy Using Cell-Free Fetal Dna in Maternal Plasma

Unexpected Findings of Duchenne Muscular Dystrophy in Prenatal Screening of Chromosome Abnormality Based on Cell-Free Fetal DNA

[Genotype, Phenotype Analysis and Follow-Up Study on Patients with Duchenne/Becker Muscular Dystrophy].

Preimplantational Genetic Diagnosis and Mutation Detection in A Family with Duplication Mutation of Dmd Gene

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

[Carrier screening model for Duchenne muscular dystrophy for women of reproductive age based on a pre-pregnancy birth defect control platform].

Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing

Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients.

Detection of duplication mutation and carriers of Duchenne/Becker muscular dystrophy by multiplex ligation-dependent probe amplification quantitative

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction